Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality

NCT00144638 is registered in ClinicalTrials.gov with Danish Procalcitonin Study Group as lead sponsor.

NCT NCT00144638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00144638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality
Lead sponsor
Danish Procalcitonin Study Group
Phase
Observational
Overall status
Completed
Start date
January 31, 2002
Completion date
January 31, 2003
Enrollment
450
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis - to reduce mortality in the intensive care unit